These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Two-year results of photodynamic therapy combined with intravitreal anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy. Kim M; Kim K; Kim DG; Yu SY; Kwak HW Ophthalmologica; 2011; 226(4):205-13. PubMed ID: 21893965 [TBL] [Abstract][Full Text] [Related]
44. A Mechanistic Model of the Intravitreal Pharmacokinetics of Large Molecules and the Pharmacodynamic Suppression of Ocular Vascular Endothelial Growth Factor Levels by Ranibizumab in Patients with Neovascular Age-Related Macular Degeneration. Hutton-Smith LA; Gaffney EA; Byrne HM; Maini PK; Schwab D; Mazer NA Mol Pharm; 2016 Sep; 13(9):2941-50. PubMed ID: 26726925 [TBL] [Abstract][Full Text] [Related]
45. Influence of ocular volume and lens status on pharmacokinetics and duration of action of intravitreal vascular endothelial growth factor inhibitors. Krohne TU; Muether PS; Stratmann NK; Holz FG; Kirchhof B; Meyer CH; Fauser S Retina; 2015 Jan; 35(1):69-74. PubMed ID: 25077535 [TBL] [Abstract][Full Text] [Related]
46. Short-term outcomes of switching anti-VEGF agents in eyes with treatment-resistant wet AMD. Batioglu F; Demirel S; Özmert E; Abdullayev A; Bilici S BMC Ophthalmol; 2015 Apr; 15():40. PubMed ID: 25885684 [TBL] [Abstract][Full Text] [Related]
48. Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis. Nakao S; Arima M; Ishikawa K; Kohno R; Kawahara S; Miyazaki M; Yoshida S; Enaida H; Hafezi-Moghadam A; Kono T; Ishibashi T Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4323-8. PubMed ID: 22661475 [TBL] [Abstract][Full Text] [Related]
49. ARE INTRAVITREAL INJECTIONS WITH ULTRATHIN 33-G NEEDLES LESS PAINFUL THAN THE COMMONLY USED 30-G NEEDLES? van Asten F; van Middendorp H; Verkerk S; Breukink MB; Lomme RM; Hoyng CB; Evers AW; Klevering BJ Retina; 2015 Sep; 35(9):1778-85. PubMed ID: 25901838 [TBL] [Abstract][Full Text] [Related]
50. Survival of Hepatitis C Virus in Syringes Is Dependent on the Design of the Syringe-Needle and Dead Space Volume. Binka M; Paintsil E; Patel A; Lindenbach BD; Heimer R PLoS One; 2015; 10(11):e0139737. PubMed ID: 26536599 [TBL] [Abstract][Full Text] [Related]
51. Effects of commonly used intravitreal anti-vascular endothelial growth factor drugs on mesenchymal stem cells derived from the limbus and ciliary body. Acar U; Erginturk Acar D; Alpaslan Pinarli F; Demir MN; Beyazyildiz E; Ozdemir O; Gulmez Sevim D; Tiryaki M; Sobaci G Clin Exp Ophthalmol; 2016 Sep; 44(7):587-596. PubMed ID: 26856706 [TBL] [Abstract][Full Text] [Related]
52. Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents. Good TJ; Kimura AE; Mandava N; Kahook MY Br J Ophthalmol; 2011 Aug; 95(8):1111-4. PubMed ID: 20702430 [TBL] [Abstract][Full Text] [Related]
53. Investigation of Two Prototypes of Novel Noncontact Technologies for Automated Real-Time Capture of Incremental Drug Administration Data From Syringes. Eagle B; Williams DJ; Dingley J Anesth Analg; 2017 Aug; 125(2):458-466. PubMed ID: 28632533 [TBL] [Abstract][Full Text] [Related]
56. Experimental investigation of needles, syringes and techniques for intravitreal injections. De Stefano VS; Abechain JJ; de Almeida LF; Verginassi DM; Rodrigues EB; Freymuller E; Maia M; Magalhaes O; Nguyen QD; Farah ME Clin Exp Ophthalmol; 2011 Apr; 39(3):236-42. PubMed ID: 20973898 [TBL] [Abstract][Full Text] [Related]
57. Assessment of the risk of needlestick injuries associated with intravitreal injections. Shah SU; Koenig MJ; Dacquay Y; Mozayan A; Hubschman JP Retina; 2014 Apr; 34(4):781-4. PubMed ID: 23975000 [TBL] [Abstract][Full Text] [Related]
58. Local and systemic complications after intravitreal administration of anti-vascular endothelial growth factor agents in the treatment of different ocular diseases: a five-year retrospective study. Nuzzi R; Tridico F Semin Ophthalmol; 2015 Mar; 30(2):129-35. PubMed ID: 24171832 [TBL] [Abstract][Full Text] [Related]
59. The Association between Needle Size and Waste Product and Its Effect on Cost-Effectiveness of Botulinum Toxin Injections? Golan S; Pena J; Moore J; Tandalam S; Lelli G Facial Plast Surg; 2020 Aug; 36(4):484-486. PubMed ID: 32688397 [TBL] [Abstract][Full Text] [Related]
60. Short-term effect of intravitreal ranibizumab on intraocular concentrations of vascular endothelial growth factor-A and pigment epithelium-derived factor in neovascular glaucoma. Wang JW; Zhou MW; Zhang X; Huang WB; Gao XB; Wang W; Chen S; Zhang XY; Ding XY; Jonas JB Clin Exp Ophthalmol; 2015 Jul; 43(5):415-21. PubMed ID: 25488632 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]